10-Q Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0001628280-22-021068`
Period End Date	20220630
Filing Date	20220804
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	arwr-20220630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 68 Cash Flow Statement 50 Stockholders Equity 34

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	105.80M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$139.44M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	104.33M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$184.43M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$10.26M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$239.00K	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	104.33M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	105.80M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$4.36M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$6.76M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.19M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$8.89M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$126.73M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	-	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$277.06M	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$56.63M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$384.60M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$432.39M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$71.90M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$48.67M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$12.39M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$13.66M	USD	Point-in-time
Long term investments	`HeldToMaturitySecuritiesNoncurrent`	$245.59M	USD	Point-in-time
Long term investments	`HeldToMaturitySecuritiesNoncurrent`	$165.92M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$68.91M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$17.35M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$275.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$272.00K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$710.15M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$751.78M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.89M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$9.46M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$32.50M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$14.00M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$9.77M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$2.65M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.88M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.25M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$84.29M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$111.06M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$146.54M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$128.21M	USD	Point-in-time
Lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$23.30M	USD	Point-in-time
Lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$78.23M	USD	Point-in-time
Deferred revenue, net of current portion	`ContractWithCustomerLiabilityNoncurrent`	$131.50M	USD	Point-in-time
Deferred revenue, net of current portion	`ContractWithCustomerLiabilityNoncurrent`	$71.16M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$154.79M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$149.39M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 145,000 shares authorized; 105,795 and 104,327 shares issued and outstanding as of June 30, 2022 and September 30, 2021, respectively	`CommonStockValue`	$198.00K	USD	Point-in-time
Common stock, $0.001 par value; 145,000 shares authorized; 105,795 and 104,327 shares issued and outstanding as of June 30, 2022 and September 30, 2021, respectively	`CommonStockValue`	$197.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.19B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.05B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-69.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-140.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-735.24M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-644.69M	USD	Point-in-time
TOTAL ARROWHEAD PHARMACEUTICALS INC. STOCKHOLDERS' EQUITY	`StockholdersEquity`	$408.82M	USD	Point-in-time
TOTAL ARROWHEAD PHARMACEUTICALS INC. STOCKHOLDERS' EQUITY	`StockholdersEquity`	$453.93M	USD	Point-in-time
Noncontrolling Interest	`MinorityInterest`	$20.25M	USD	Point-in-time
Noncontrolling Interest	`MinorityInterest`	-	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$461.78M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$408.82M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$452.27M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$445.55M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$474.18M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$436.89M	USD	Point-in-time
TOTAL LIABILITIES, NONCONTROLLING INTEREST AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$751.78M	USD	Point-in-time
TOTAL LIABILITIES, NONCONTROLLING INTEREST AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$710.15M	USD	Point-in-time

Income Statement 68 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$45.89M	USD	1 Quarter
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$32.41M	USD	1 Quarter
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$100.00M	USD	3 Qtrs
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$211.66M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$72.18M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$59.33M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$213.93M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$140.58M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$92.40M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$18.43M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$33.14M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$43.58M	USD	3 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$77.76M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$306.33M	USD	3 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$184.16M	USD	3 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$105.32M	USD	1 Quarter
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$-94.68M	USD	3 Qtrs
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$-72.91M	USD	1 Quarter
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$-84.15M	USD	3 Qtrs
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$-31.87M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$3.45M	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$4.97M	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$1.28M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$1.24M	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$664.00K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$675.00K	USD	3 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-377.00K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$1.71M	USD	3 Qtrs
TOTAL OTHER INCOME	`NonoperatingIncomeExpense`	$1.94M	USD	1 Quarter
TOTAL OTHER INCOME	`NonoperatingIncomeExpense`	$863.00K	USD	1 Quarter
TOTAL OTHER INCOME	`NonoperatingIncomeExpense`	$4.12M	USD	3 Qtrs
TOTAL OTHER INCOME	`NonoperatingIncomeExpense`	$6.68M	USD	3 Qtrs
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-90.55M	USD	3 Qtrs
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-29.92M	USD	1 Quarter
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-77.47M	USD	3 Qtrs
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-72.05M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$-72.05M	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-29.92M	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-90.55M	USD	3 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$-77.47M	USD	3 Qtrs
NET INCOME (LOSS) PER SHARE - BASIC (in dollars per share)	`EarningsPerShareBasic`	$-0.75	USD	3 Qtrs
NET INCOME (LOSS) PER SHARE - BASIC (in dollars per share)	`EarningsPerShareBasic`	$-0.29	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - BASIC (in dollars per share)	`EarningsPerShareBasic`	$-0.86	USD	3 Qtrs
NET INCOME (LOSS) PER SHARE - BASIC (in dollars per share)	`EarningsPerShareBasic`	$-0.68	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - DILUTED (in dollars per share)	`EarningsPerShareDiluted`	$-0.86	USD	3 Qtrs
NET INCOME (LOSS) PER SHARE - DILUTED (in dollars per share)	`EarningsPerShareDiluted`	$-0.75	USD	3 Qtrs
NET INCOME (LOSS) PER SHARE - DILUTED (in dollars per share)	`EarningsPerShareDiluted`	$-0.29	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - DILUTED (in dollars per share)	`EarningsPerShareDiluted`	$-0.68	USD	1 Quarter
Weighted average shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	105.27M	shares	3 Qtrs
Weighted average shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	103.57M	shares	3 Qtrs
Weighted average shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	105.75M	shares	1 Quarter
Weighted average shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	104.10M	shares	1 Quarter
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	105.27M	shares	3 Qtrs
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	103.57M	shares	3 Qtrs
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	104.10M	shares	1 Quarter
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	105.75M	shares	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-40.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-71.00K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$44.00K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-33.00K	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$-72.08M	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$-90.62M	USD	3 Qtrs
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$-29.96M	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$-77.43M	USD	3 Qtrs

Cash Flow Statement 50 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-72.05M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-29.92M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-90.55M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-77.47M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$42.05M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$91.70M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$5.76M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$7.76M	USD	3 Qtrs
Unrealized (gains) losses on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$1.39M	USD	3 Qtrs
Unrealized (gains) losses on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-5.75M	USD	3 Qtrs
Amortization/(accretion) of note premiums/discounts	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-142.00K	USD	3 Qtrs
Amortization/(accretion) of note premiums/discounts	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-2.01M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-174.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-10.02M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.90M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$8.88M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$211.39M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-87.10M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-3.56M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.21M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.71M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$13.68M	USD	3 Qtrs
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$685.00K	USD	3 Qtrs
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$3.67M	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-67.46M	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$195.34M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$15.37M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$20.07M	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$95.19M	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$223.39M	USD	3 Qtrs
Proceeds from sale of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$201.59M	USD	3 Qtrs
Proceeds from sale of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$87.13M	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-23.43M	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-41.86M	USD	3 Qtrs
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$4.33M	USD	3 Qtrs
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$10.49M	USD	3 Qtrs
Proceeds from investment in joint venture	`ProceedsFromContributedCapital`	-	USD	3 Qtrs
Proceeds from investment in joint venture	`ProceedsFromContributedCapital`	$60.00M	USD	3 Qtrs
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$64.33M	USD	3 Qtrs
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$10.49M	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$182.40M	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-44.99M	USD	3 Qtrs
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$325.98M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$184.43M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$143.58M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$139.44M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$325.98M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$184.43M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$143.58M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$139.44M	USD	Point-in-time

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$461.78M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$408.82M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$452.27M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$445.55M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$474.18M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$436.89M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$18.55M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$33.39M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$42.05M	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$91.70M	USD	3 Qtrs
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.28M	USD	3 Qtrs
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$599.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$10.49M	USD	3 Qtrs
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.76M	USD	1 Quarter
Exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	506,596.00	shares	3 Qtrs
Common stock - restricted stock units vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	3 Qtrs
Common stock - restricted stock units vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Common stock - restricted stock units vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-40.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-71.00K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$44.00K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-33.00K	USD	1 Quarter
Interest in joint venture	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$60.00M	USD	1 Quarter
Interest in joint venture	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$60.00M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-72.05M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-29.92M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-90.55M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-77.47M	USD	3 Qtrs
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$461.78M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$408.82M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$452.27M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$445.55M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$474.18M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$436.89M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.